Sign In
Buy AMED
$100.99
+0 (+0%)
At Close: Nov 13, 2025
Amedisys, Inc. (AMED) Q4 2022 Earnings Call Transcript
04:28pm, Thursday, 16'th Feb 2023
Amedisys, Inc. (NASDAQ:AMED ) Q4 2022 Earnings Conference Call February 16, 2023 11:00 AM ET Company Participants Nick Muscato - Chief Strategy Officer Paul Kusserow - Chairman & CEO Scott Ginn - EVP,
Amedisys (AMED) Surpasses Q4 Earnings and Revenue Estimates
07:34pm, Wednesday, 15'th Feb 2023
Amedisys (AMED) delivered earnings and revenue surprises of 12.62% and 0.36%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Amedisys Announces Fourth Quarter and Year End Earnings Release and Conference Call Dates
08:00am, Monday, 30'th Jan 2023
BATON ROUGE, La., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the f
Amedisys (AMED) Faces Macro Challenges, Margin Pressure
01:32pm, Thursday, 05'th Jan 2023
The Contessa Health acquisition seems to be strategically aligned with Amedisys' (AMED) business.
Amedisys to Present at the 41st Annual J.P. Morgan Healthcare Conference
08:00am, Wednesday, 28'th Dec 2022
BATON ROUGE, La., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow
Amedisys to Present at Bank of America Securities Home Care Conference
05:30pm, Friday, 02'nd Dec 2022
BATON ROUGE, La., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care, today announced that Paul B. Kusserow
Amedisys: No Change To Thesis, Retain Hold
04:36am, Wednesday, 23'rd Nov 2022
Company CEO departed last week, although management reaffirmed FY22 guidance. Speaking of guidance, growth at the top–bottom lines was narrowed down on the Q3 earnings call.
Amedisys (AMED) Q3 Earnings Miss Estimates, Guidance Cut
01:34pm, Monday, 31'st Oct 2022
Within Amedisys (AMED) Home Health and Hospice, the reinstatement of sequestration reduces growth in Q3.
Amedisys, Inc. (AMED) Q3 2022 Earnings Call Transcript
05:42pm, Thursday, 27'th Oct 2022
Amedisys, Inc. (NASDAQ:AMED ) Q3 2022 Earnings Conference Call October 27, 2022 11:00 AM ET Company Participants Nick Muscato – Chief Strategy Officer Chris Gerard – President and Chief Executive
Amedisys (AMED) Misses Q3 Earnings and Revenue Estimates
06:49pm, Wednesday, 26'th Oct 2022
Amedisys (AMED) delivered earnings and revenue surprises of -7.26% and 3.41%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Stocks to Watch From the Pandemic-Hit Outpatient Home Health Industry
12:47pm, Thursday, 29'th Sep 2022
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. AMED, ADUS and HNGR are w
Here's Why Investors Should Retain Amedisys (AMED) Stock for Now
12:02pm, Friday, 23'rd Sep 2022
Investors are optimistic about Amedisys' (AMED) better-than-expected earnings and notable buyouts.
Amedisys Inc (AMED) CEO Chris Gerard on Q2 2022 Results - Earnings Call Transcript
05:10pm, Thursday, 28'th Jul 2022
Amedisys Inc (NASDAQ:AMED ) Q2 2022 Earnings Conference Call July 28, 2022 11:00 AM ET Company Participants Nick Muscato - Chief Strategy Officer Chris Gerard - President and Chief Executive Officer S
Amedisys (AMED) Q2 Earnings Beat Estimates
07:21pm, Wednesday, 27'th Jul 2022
Amedisys (AMED) delivered earnings and revenue surprises of 19.51% and 4.10%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Amedisys Announces Second Quarter 2022 Earnings Release and Conference Call Date
08:00am, Wednesday, 06'th Jul 2022
BATON ROUGE, La., July 06, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, will report results for the s
